drug
as of 2026-07-01Valproate
valproate
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alzheimer's Disease Cooperative Study (ADCS)
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
4
Valproate in Dementia (VALID)
NCT00071721Phase 3Completed
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
NCT00167934—Completed
Valproate in Late Life Schizophrenia
NCT00194025Phase 4Completed
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558—Completed
KOLs & investigators
5
Martha Sajatovic, MDKOL score 7
Professor Gary Donohoe, Ph.D.KOL score 5
Michael C Davis, M.D., Ph.D.KOL score 5
Pierre Tariot, MDKOL score 2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Martha Sajatovic, MD
personKOL score 7
Professor Gary Donohoe, Ph.D.
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5
Pierre Tariot, MD
personKOL score 2